Modulation of mood states as a major factor in relapse to substance use

Frontiers in Molecular Neuroscience

Volumn , Issue JUNE 2012, 2012, Pages

  Yadid, Gal ^a   Redlus, Lior ^a   Barnea, Royi ^a   Doron, Ravid ^b,c  

^a BAR ILAN UNIVERSITY   (Israel)

^b OPEN UNIVERSITY OF ISRAEL   (Israel)

^c Hadassah Academic College   (Israel)

Author keywords

Abstinence; Addiction; Anxiety; Dehydroepiandrosterone; Depression; Neurosteroids; Opioids; Stress

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BETA ENDORPHIN; BUSPIRONE; DELTA OPIATE RECEPTOR; DESIPRAMINE; KAPPA OPIATE RECEPTOR; NALTRINDOLE; NEUROPEPTIDE; ONDANSETRON; PRASTERONE; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR;

ANXIETY DISORDER; ARTICLE; CHRONIC STRESS; COCAINE DEPENDENCE; DEPRESSION; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DEPENDENCE; DRUG MEGADOSE; DRUG SEEKING BEHAVIOR; DYSPHORIA; HEROIN DEPENDENCE; HUMAN; MOOD DISORDER; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; PROTEIN FUNCTION; PSYCHOSOCIAL CARE; RELAPSE; RISK FACTOR; SEROTONINERGIC SYSTEM; SMOKING HABIT; SUBSTANCE ABUSE; THERAPY EFFECT; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

EID: 84864014057     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2012.00081     Document Type: Article

References (56)

1. Akil, H., S. J. Watson, E. Young, M. E. Lewis, H. Khachaturian, and J. M. Walker. 1984. Endogenous opioids: biology and function. Annu Rev Neurosci 7:223-55.
2. Belujon, P., and A. A. Grace. 2011. Hippocampus, amygdala, and stress: interacting systems that affect susceptibility to addiction. Ann N Y Acad Sci 1216:114-21.
3. Boutrel, B., and L. de Lecea. 2008. Addiction and arousal: the hypocretin connection. Physiol Behav 93 (4-5):947-51.
4. Bruchas, M. R., B. B. Land, and C. Chavkin. 2010. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res 1314:44-55.
5. Bruijnzeel, A. W. 2012. Tobacco addiction and the dysregulation of brain stress systems. Neurosci Biobehav Rev 36 (5):1418-1441.
6. Charalampopoulos, I., E. Remboutsika, A. N. Margioris, and A. Gravanis. 2008. Neurosteroids as modulators of neurogenesis and neuronal survival. Trends EndocrinolMetab 19 (8):300-7.
7. Citó, M. o C, F. C. da Silva, M. I. Silva, B. A. Moura, D. S. Macêdo, D. J. Woods, M. M. Fonteles, S. M. Vasconcelos, and F. C. Sousa. 2012. Reversal of cocaine withdrawal-induced anxiety by ondansetron, buspirone and propranolol. Behav Brain Res 231 (1):116-23.
8. Costall, B., and R. J. Naylor. 1992. Anxiolytic potential of 5-HT3 receptor antagonists. Pharmacol Toxicol 70 (3):157-62.
9. de Lecea, L., M. E. Carter, and A. Adamantidis. 2012. Shining Light on Wakefulness and Arousal. Biol Psychiatry.
10. de Vries, T. J., D. Babovic-Vuksanovic, G. Elmer, and T. S. Shippenberg. 1995. Lack of involvement of delta-opioid receptors in mediating the rewarding effects of cocaine. Psychopharmacology (Berl) 120 (4):442-8.
11. Doron, R., L. Fridman, I. Gispan-Herman, R. Maayan, A. Weizman, and G. Yadid. 2006. DHEA, a neurosteroid, decreases cocaine self-administration and reinstatement of cocaine-seeking behavior in rats. Neuropsychopharmacology.
12. Doron, R., L. Fridman, and G. Yadid. 2006. Dopamine-2 receptors in the arcuate nucleus modulate cocaine-seeking behavior. Neuroreport 17 (15):1633-1636.
13. Flood, J. F., G. E. Smith, and E. Roberts. 1988. Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res 447 (2):269-78.
14. Froeliger, B., L. A. Modlin, R. V. Kozink, L. Wang, and F. J. McClernon. 2012. Smoking abstinence and depressive symptoms modulate the executive control system during emotional information processing. Addict Biol 17 (3):668-79.
15. Garland, E. L., K. Carter, K. Ropes, and M. O. Howard. 2012. Thought suppression, impaired regulation of urges, and Addiction-Stroop predict affect-modulated cue-reactivity among alcohol dependent adults. Biol Psychol 89 (1):87-93.
16. Ghitza, U. E., K. L. Preston, D. H. Epstein, H. Kuwabara, C. J. Endres, B. Bencherif, S. J. Boyd, M. L. Copersino, J. J. Frost, and D. A. Gorelick. 2010. Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients. Biol Psychiatry 68 (8):697-703.
17. Kalivas, P. W., and N. D. Volkow. 2005. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162 (8): 1403-13.
18. Kirby, L. G., F. D. Zeeb, and C. A. Winstanley. 2011. Contributions of serotonin in addiction vulnerability. Neuropharmacology 61 (3):421-32.
19. Koob, G. F., and E. P. Zorrilla. 2010. Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor. Curr Opin Investig Drugs 11 (1):63-71.
20. Kreek, M. J., Y. Zhou, E. R. Butelman, and O. Levran. 2009. Opiate and cocaine addiction: from bench to clinic and back to the bench. Curr Opin Pharmacol 9 (1):74-80.
21. Kuzmin, A. V., S. Semenova, M. A. Gerrits, E. E. Zvartau, and J. M. Van Ree. 1997. Kappa-opioid receptor agonist U50, 488H modulates cocaine and morphine self-administration in drug-naive rats and mice. Eur J Pharmacol 321 (3):265-71.
22. Le Merrer, J., K. Befort, O. Gardon, D. Filliol, E. Darcq, D. Dembele, J. A. Becker, and B. L. Kieffer. 2012. Protracted abstinence from distinct drugs of abuse shows regulation of a common gene network. Addict Biol 17 (1): 1-12.
23. Leelarungrayub, D., S. Pratanaphon, P. Pothongsunun, T. Sriboonreung, A. Yankai, and R. J. Bloomer. Vernonia cinerea Less. supplementation and strenuous exercise reduce smoking rate: relation to oxidative stress status and beta-endorphin release in active smokers. JInt Soc Sports Nutr 7:21.
24. Li, Y. Q., F. Q. Li, X. Y. Wang, P. Wu, M. Zhao, C. M. Xu, Y. Shaham, and L. Lu. 2008. Central amygdala extracellular signal-regulated kinase signaling pathway is critical to incubation of opiate craving. J Neurosci 28 (49):13248-57.
25. Logrip, M. L., P. H. Janak, and D. Ron. 2008. Dynorphin is a downstream effector of striatal BDNF regulation of ethanol intake. FASEB J 22 (7):2393-404.
26. Longoni, R., C. Cadoni, A. Mulas, G. Di Chiara, and L. Spina. 1998. Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 2. Place-preference and brain microdialysis studies in rats. Behav Pharmacol 9 (1):9-14.
27. Lu, L., J. D. Shepard, F. S. Hall, and Y. Shaham. 2003. Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a review. Neurosci Biobehav Rev 27 (5):457-91.
28. Maayan, R., D. Touati-Werner, D. Shamir, G. Yadid, A. Friedman, D. Eisner, A. Weizman, and I. Herman. 2008. The effect of DHEA complementary treatment on heroin addicts participating in a rehabilitation program: a preliminary study. Eur Neuropsychopharmacol 18 (6):406-13.
29. Malkesman, O., Y. Braw, R. Maayan, A. Weizman, D.H. Overstreet, M. Shabat-Simon, Y. Kesner, D. Touati-Werner, G. Yadid, and A. Weller. 2006. Two different putative genetic animal models of childhood depression. Biol. Psychiatry 59 (1): 17-23.
30. Marquez, P., R. Baliram, I. Dabaja, N. Gajawada, and K. Lutfy. 2008. The role of beta-endorphin in the acute motor stimulatory and rewarding actions of cocaine in mice. Psychopharmacology (Berl) 197 (3):443-8.
31. Merenlender-Wagner, A., Y. Dikshtein, and G. Yadid. 2009. The beta-endorphin role in stress-related psychiatric disorders. Curr Drug Targets 10 (11): 1096-108.
32. Moeller, F. G. 2012. Sex, stress, and drug cues in addiction. Am J Psychiatry 169 (4):351-3.
33. Morales, A.J., J.J. Nolan, J.C. Nelson, and S.S. Yen. 1994. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. EndocrinolMetab 78 (6):1360-1367.
34. Negus, S. S., M. B. Gatch, N. K. Mello, X. Zhang, and K. Rice. 1998. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. J Pharmacol Exp Ther 286 (1):362-75.
35. Nestler, E. J. 2005. Is there a common molecular pathway for addiction? Nat Neurosci 8 (11): 1445-9.
36. Packard, M. G. 2009. Anxiety, cognition, and habit: a multiple memory systems perspective. Brain Res 1293:121-8.
37. Pani, P. P., E. Trogu, S. Vecchi, and L. Amato. 2011. Antidepressants for cocaine dependence and problematic cocaine use. Cochrane Database Syst Rev (12):CD002950.
38. Perrine, S. A., I. S. Sheikh, C. A. Nwaneshiudu, J. A. Schroeder, and E. M. Unterwald. 2008. Withdrawal from chronic administration of cocaine decreases delta opioid receptor signaling and increases anxiety-and depression-like behaviors in the rat. Neuropharmacology 54 (2):355-64.
39. Reid, L. D., S. D. Glick, K. A. Menkens, E. D. French, E. J. Bilsky, and F. Porreca. 1995. Cocaine selfadministration and naltrindole, a delta-selective opioid antagonist. Neuroreport 6 (10):1409-12.
40. Roth-Deri, I., T. Green-Sadan, and G. Yadid. 2008. Beta-endorphin and drug-induced reward and reinforcement. Prog Neurobiol 86 (1):1-21.
41. Roth-Deri, I., T. Green-Sadan, and G. Yadid. 2008. Beta-endorphin and drug-induced reward and reinforcement. Prog Neurobiol 86 (1):1-21.
42. Rounsaville, B. J. 2004. Treatment of cocaine dependence and depression. Biol Psychiatry 56 (10):803-9.
43. Shaw, D., and M. al'Absi. 2008. Attenuated beta endorphin response to acute stress is associated with smoking relapse. PharmacolBiochem Behav 90 (3):357-62.
44. Simmons, D., and D. W. Self. 2009. Role of mu-and delta-opioid receptors in the nucleus accumbens in cocaine-seeking behavior. Neuropsychopharmacology 34 (8):1946-57.
45. Sinha, R. 2011. New findings on biological factors predicting addiction relapse vulnerability. Curr Psychiatry Rep 13 (5):398-405.
46. Stulz, N., M. E. Thase, R. Gallop, and P. Crits-Christoph. 2011. Psychosocial treatments for cocaine dependence: the role of depressive symptoms. Drug Alcohol Depend 114 (1):41-8.
47. Tang, X. C., K. McFarland, S. Cagle, and P. W. Kalivas. 2005. Cocaine-induced reinstatement requires endogenous stimulation of mu-opioid receptors in the ventral pallidum. J Neurosci 25 (18):4512-20.
48. Ulmann, L., J. L. Rodeau, L. Danoux, J. L. Contet-Audonneau, G. Pauly, and R. Schlichter. 2009. Dehydroepiandrosterone and neurotrophins favor axonal growth in a sensory neuron-keratinocyte coculture model. Neuroscience 159 (2):514-25.
49. Ward, S. J., and D. C. Roberts. 2007. Microinjection of the delta-opioid receptor selective antagonist naltrindole 5'-isothiocyanate site specifically affects cocaine self-administration in rats responding under a progressive ratio schedule of reinforcement. Behav Brain Res 182 (1):140-4.
50. Wee, S., and G. F. Koob. 2010. The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology (Berl) 210 (2): 121-35.
51. Wee, S., L. Orio, S. Ghirmai, J. R. Cashman, and G. F. Koob. 2009. Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine. Psychopharmacology (Berl) 205 (4):565-75.
52. Weiss, F., R. Ciccocioppo, L. H. Parsons, S. Katner, X. Liu, E. P. Zorrilla, G. R. Valdez, O. Ben-Shahar, S. Angeletti, and R. R. Richter. 2001. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann N YAcad Sci 937:1-26.
53. Wolkowitz, O.M., and V.I. Reus. 1999. Treatment of depression with antiglucocorticoid drugs. Psychosom. Med. 61 (5):698-711.
54. Xi, Z. X., S. A. Fuller, and E. A. Stein. 1998. Dopamine release in the nucleus accumbens during heroin selfadministration is modulated by kappa opioid receptors: an in vivo fast-cyclic voltammetry study. J Pharmacol Exp Ther 284 (1): 151-61.
55. Yadid, G., E. Sudai, R. Maayan, I. Gispan, and A. Weizman. 2010. The role of dehydroepiandrosterone (DHEA) in drug-seeking behavior. NeurosciBiobehavRev 35 (2):303-14.
56. Zalewska-Kaszubska, J., D. Gorska, W. Dyr, and E. Czarnecka. 2008. Effect of chronic acamprosate treatment on voluntary alcohol intake and beta-endorphin plasma levels in rats selectively bred for high alcohol preference. Neurosci Lett 431 (3):221-5.